tiprankstipranks
CymaBay Therapeutics (GB:0I5P)
LSE:0I5P

CymaBay Therapeutics (0I5P) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
CymaBay Therapeutics’s (0I5P) Moving Averages Convergence Divergence (MACD) indicator is 0.71, suggesting CymaBay Therapeutics is a Buy.
CymaBay Therapeutics’s (0I5P) 20-Day exponential moving average is 32.10, while CymaBay Therapeutics’s (0I5P) share price is $32.483, making it a Buy.
CymaBay Therapeutics’s (0I5P) 50-Day exponential moving average is 29.70, while CymaBay Therapeutics’s (0I5P) share price is $32.483, making it a Buy.

CymaBay Therapeutics (0I5P) Pivot Points

Apr 27, 2024, 04:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
32.48
32.48
32.48
32.48
32.48
32.48
32.48
Fibonacci
32.48
32.48
32.48
32.48
32.48
32.48
32.48
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

CymaBay Therapeutics (0I5P) Moving Averages

Apr 27, 2024, 04:12 PM
Period
Simple
Exponential
MA5
32.48Buy
32.48Buy
MA10
32.47Buy
32.45Buy
MA20
32.39Buy
32.10Buy
MA50
29.42Buy
29.70Buy
MA100
25.00Buy
25.92Buy
MA200
19.00Buy
20.27Buy
CymaBay Therapeutics’s (0I5P) 10-Day exponential moving average is 32.45, while CymaBay Therapeutics’s (0I5P) share price is $32.483, making it a Buy.
CymaBay Therapeutics’s (0I5P) 100-Day exponential moving average is 25.92, while CymaBay Therapeutics’s (0I5P) share price is $32.483, making it a Buy.
CymaBay Therapeutics’s (0I5P) stock price is $32.483 and CymaBay Therapeutics’s (0I5P) 50-day simple moving average is 29.42, creating a Buy signal.
CymaBay Therapeutics’s (0I5P) stock price is $32.483 and CymaBay Therapeutics’s (0I5P) 100-day simple moving average is 25.00, creating a Buy signal.
CymaBay Therapeutics’s (0I5P) stock price is $32.483 and CymaBay Therapeutics’s (0I5P) 200-day simple moving average is 19.00, creating a Buy signal.

CymaBay Therapeutics (0I5P) Technical Indicators

Apr 27, 2024, 04:12 PM
Name
Value
Implied Action
RSI (14)
83.81
Sell
STOCH (9,6)
61.48
Neutral
STOCHRSI (14)
88.05
Sell
MACD (12,26)
0.71
Buy
ADX (14)
57.95
Sell
Williams %R
-12.86
Sell
CCI (14)
62.87
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
61.94
Neutral
ROC
0.64
Buy
CymaBay Therapeutics’s (0I5P) Relative Strength Index (RSI) is 83.81, creating a Sell signal.
CymaBay Therapeutics’s (0I5P) Trend Strength Indicator (ADX) is 57.95, creating a Sell signal.
CymaBay Therapeutics’s (0I5P) Commodity Channel Index (CCI) is 62.87, creating a Neutral signal.
CymaBay Therapeutics’s (0I5P) Price Rate of Change (ROC) is 0.64, creating a Buy signal.

FAQ

Is 0I5P a Buy, Hold, or Sell?
Based on 0I5P’s technical indicators, 0I5P is a Buy.
    What is 0I5P’s RSI (14)?
    0I5P’s RSI (14) is 83.81, which suggests 0I5P is a Sell.
      What is 0I5P’s MACD?
      0I5P’s MACD is 0.71, which suggests 0I5P is a Buy.
        What is 0I5P’s 5-day moving average?
        0I5P’s 5-day moving average is 32.48, which suggests 0I5P is a Buy.
          What is 0I5P’s 20-day moving average?
          0I5P 20-day moving average is 32.39, which suggests 0I5P is a Buy.
            What is 0I5P’s 50-day moving average?
            0I5P’s 50-day moving average is 29.42, which suggests 0I5P is a Buy.
              What is 0I5P’s 200-day moving average?
              0I5P’s 200-day moving average is 19.00, which suggests 0I5P is a Buy.
                What is 0I5P’s Williams % R (14)?
                0I5P’s Williams % R (14) is -12.86, which suggests 0I5P is a Sell.
                  What is 0I5P’s CCI (14)?
                  0I5P’s CCI (14) is 62.87, which suggests 0I5P is a Neutral.
                    What is the share price of CymaBay Therapeutics?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis